Enumera Molecular
Ann Arbor, US · Founded 2022 · Delaware corporation · 1 known investors
Enumera Molecular develops the EnumeraPlex platform, a molecular diagnostics system offering a range of tests with a single workflow and clear result readouts for clinical laboratories. It targets application areas including oncology, reproductive health, transplant, pharmacogenomics, and infectious disease testing.
Founders & leadership
MC
Matthew CooperCEO & Co-founder
DK
Dan KidleDirector
EH
Elaine HeronDirector
SB
Sundaresh BrahmasandraDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$12.3MraisedJul 2026 · 12 investors · Other Health CareRule 506(b)
▶$12.3MraisedJul 2026 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew CooperExecutive Officer, Director
- Dan KidleDirector
- Elaine HeronDirector
- Sundaresh BrahmasandraDirector
- Offering amount
- $17.4M
- Amount sold
- $12.3M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$18.7MraisedAug 2022 · 5 investors · Other Health CareRule 506(b)
▶$18.7MraisedAug 2022 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew CooperExecutive Officer, Director
- Offering amount
- $19M
- Amount sold
- $18.7M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.